2020
DOI: 10.1016/j.celrep.2020.02.108
|View full text |Cite
|
Sign up to set email alerts
|

Multi-scale Predictions of Drug Resistance Epidemiology Identify Design Principles for Rational Drug Design

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

1
20
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(23 citation statements)
references
References 52 publications
1
20
1
Order By: Relevance
“…Secondly, the discovery of a direct influence of mutation bias on evolutionary adaptation parallels recent reports that driver mutations in cancer reflect the underlying biases of cancer-associated mutational processes, including exogenous effects of UV light and tobacco exposure, and endogenous effects of DNA mismatch repair and APOBEC activity [49][50][51]. The increased predictability of such changes, due to mutational effects, can inform rational drug design, as has been suggested for drugs for leukemia, prostate cancer, breast cancer, and gastrointestinal stromal tumors [26]. The same may be true for designing antibiotic treatments for mycobacteria, which evolve multi-drug resistance via a sequence of mutations, several of which interact epistatically, such that only a subset of possible mutational trajectories to multi-drug resistance are possible [52].…”
Section: Discussionmentioning
confidence: 61%
See 2 more Smart Citations
“…Secondly, the discovery of a direct influence of mutation bias on evolutionary adaptation parallels recent reports that driver mutations in cancer reflect the underlying biases of cancer-associated mutational processes, including exogenous effects of UV light and tobacco exposure, and endogenous effects of DNA mismatch repair and APOBEC activity [49][50][51]. The increased predictability of such changes, due to mutational effects, can inform rational drug design, as has been suggested for drugs for leukemia, prostate cancer, breast cancer, and gastrointestinal stromal tumors [26]. The same may be true for designing antibiotic treatments for mycobacteria, which evolve multi-drug resistance via a sequence of mutations, several of which interact epistatically, such that only a subset of possible mutational trajectories to multi-drug resistance are possible [52].…”
Section: Discussionmentioning
confidence: 61%
“…A growing body of evidence suggests that specific mutation biases influence the types of genetic changes that cause adaptation [5,[19][20][21][22][23][24][25][26], consistent with a small body of theoretical work on how biases in the introduction of variationboth low-level mutational biases and higher-level systemic biases-are expected to influence evolution [33][34][35][36]. Here, we have developed and applied a general approach to assess how the mutation spectrum shapes the spectrum of adaptive substitutions.…”
Section: Discussionmentioning
confidence: 67%
See 1 more Smart Citation
“…By altering the pool of mutations available for selection, mutation spectra may determine the genetic basis of adaptation (10,13,14) and drive convergent evolution (15,16). Finally, from a practical standpoint, mutational biases can shape the evolution of resistance to antibiotics (11,17,18) and anticancer drugs (19). However, we lack direct experimental evidence demonstrating the fitness consequences of mutation spectra.…”
mentioning
confidence: 99%
“… 18 ). At the same time, multiple studies have now shown that adaptive substitutions are enriched for mutationally likely changes ( 5 , 19 27 ). For instance, the influence of a mutational bias favoring transitions is evident in the evolution of antibiotic resistance in Mycobacterium tuberculosis ( 5 ).…”
mentioning
confidence: 99%